Page last updated: 2024-11-03

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Temporomandibular Disorders

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Temporomandibular Disorders in 2 studies

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oliveira, MC1
Parada, CA1
Veiga, MC1
Rodrigues, LR1
Barros, SP1
Tambeli, CH1
Shinoda, M1
Ozaki, N1
Asai, H1
Nagamine, K1
Sugiura, Y1

Other Studies

2 other studies available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Temporomandibular Disorders

ArticleYear
Evidence for the involvement of endogenous ATP and P2X receptors in TMJ pain.
    European journal of pain (London, England), 2005, Volume: 9, Issue:1

    Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Arthralgia; Arthritis; Carrageenan; Disea

2005
Changes in P2X3 receptor expression in the trigeminal ganglion following monoarthritis of the temporomandibular joint in rats.
    Pain, 2005, Volume: 116, Issue:1-2

    Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Arthritis; Cell Count; Drug Interactions; Fac

2005